Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Cardiologist makes history with first commercial implant of new pacing lead for LBBAP
The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States.
FDA approves smallest defibrillation lead of its kind for LBBA placement
The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.
Cardiology now has more than 200 FDA-cleared AI algorithms
Cardiology is No. 2 behind radiology when it comes to FDA-cleared AI algorithms. Neurology, meanwhile, is a distant No. 3.
FDA shares details about reprocessed catheter recall
Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.
Boston Scientific’s Farapulse PFA system receives expanded approval
The technology first gained CE mark approval for the treatment of paroxysmal AFib in 2021, when PFA was still brand new. Now, thanks to positive results from the ADVANTAGE AF clinical trial, it is approved for persistent AFib as well.

What peridevice leaks after LAAO mean for patient health

The study's authors reviewed data from more than 50,000 patients, presenting their findings in JACC: Clinical Electrophysiology.

3D cardiac modeling solution for VT ablation receives FDA clearance

The new software solution was designed with ventricular tachycardia ablation and other cardiac ablation procedures in mind.

Left bundle branch block after TAVR hurts outcomes, even when no permanent pacemaker is required

Researchers tracked data from more than 2,000 TAVR patients, focusing on cardiovascular mortality and hospitalizations for heart failure.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes.

Brugada arrhythmogenic substrate that causes VT and sudden cardiac death. This study showed ablation of this substrate area could help prevent sudden cardiac arrest in these patients.

Epicardial ablation in Brugada syndrome reduces sudden cardiac death

A late-breaking study at Heart Rhythm 2022 found epicardial ablation in Brugada syndrome helped significantly reduce sudden cardiac arrest in these patients, increasing their survival.

Same-day discharge for AFib ablation a success thanks to telehealth

The new analysis, presented during Heart Rhythm 2022, focused on patients treated at a high-volume facility during the COVID-19 pandemic.

VIDEO: How to implant a Linq implantable cardiac monitor

The Medtronic Linq and Linq II implantable cardiac monitors (ICM) have become some of the most popular ICM devices on the market, partly because they are easy to insert.

Electrophysiology

Cardiologist makes history with first commercial implant of new pacing lead for LBBAP

FDA approves smallest defibrillation lead of its kind for LBBA placement

Cardiology now has more than 200 FDA-cleared AI algorithms

FDA shares details about reprocessed catheter recall

Boston Scientific’s Farapulse PFA system receives expanded approval